证券代码：600568 证券简称：ST 中珠 公告编号：2026-011 号 中珠医疗控股股份有限公司 2026 年 2 月 9 日，公司董事会收到持股 10%以上股东共青城梅花腾龙起飞投 资合伙企业(有限合伙) （以下简称"梅花投资"）送达的《关于中珠医疗控股股 份有限公司非独立董事候选人提名函》（以下简称"《提名函》"）。 《提名函》表示，作为公司持股 10%以上的股东，根据《公司法》《上海证 券交易所股票上市规则》等法律法规、规范性文件及《公司章程》的有关规定， 现提名吴世春先生为公司第十届董事会非独立董事候选人。 从主体资格来看，梅花投资持有公司 206,821,844 股股份，占公司总股本的 10.38%，具备向公司董事会提名非独立董事（职工代表董事除外）候选人的资格。 符合《中华人民共和国公司法》《公司章程》的有关规定。 三、公司董事会审议的情况 关于补选公司第十届董事会非独立董事的公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 中珠医疗控股股份有限公司（以下简称"中珠医疗"或"公司"）于 2 ...

中珠医疗控股股份有限公司 ZhongZhu Healthcare Holding Co.，Ltd 2026 年第一次临时股东会 会议资料 二〇二六年三月十二日 中国·珠海 2026 年第一次临时股东会会议资料 目 录 审议《关于补选公司第十届董事会非独立董事的议案》。 - 2 - 一、2026 年第一次临时股东会会议议程 二、2026 年第一次临时股东会会议须知 三、2026 年第一次临时股东会表决办法 四、会议议案 2026 年第一次临时股东会会议资料 中珠医疗控股股份有限公司 2026 年第一次临时股东会会议议程 会议议程： 一、主持人宣布现场会议开始。 审议《关于补选公司第十届董事会非独立董事的议案》。 十、现场股东会复会（获取交易所统计的投票表决结果），股东会监票人员代 表当场宣布表决结果。 十一、股东会见证律师发表见证意见。 - 3 - 时 间：二〇二六年三月十二日 上午 10:00 地 点：珠海市情侣南路 1 号仁恒滨海中心 5 座 8 层 主持人：董事长陈旭先生 二、宣读 2026 年第一次临时股东会会议须知。 三、宣读 2026 年第一次临时股东会表决办法。 四、报告出席现场会议的股东人数及其 ...

Core Viewpoint - The company ST Zhongzhu is involved in a legal dispute regarding a rental contract with Hongjie Runzhong, with a total amount in question of 513 million yuan. The case is currently in the final ruling stage concerning jurisdictional objections and has not yet gone to trial. The company has completed the eviction of the property as per the judgment but believes that Hongjie Runzhong should bear the responsibility for the contract's invalidity. The outcome of the ruling is not expected to impact the company's current or future profits [1]. Group 1 - The legal dispute involves a rental contract with a total amount of 513 million yuan [1] - The case is at the final ruling stage regarding jurisdictional objections and has not yet gone to trial [1] - The company has completed the eviction of the property as per the judgment [1] Group 2 - The company believes that Hongjie Runzhong should bear the responsibility for the contract's invalidity [1] - The outcome of the ruling is not expected to affect the company's current or future profits [1]

Stock Price Movement Reasons - A major shareholder, Shenzhen Zhongshengyuan Enterprise Management Center (Limited Partnership), plans to reduce its stake by up to 59,786,089 shares (3% of total share capital) due to funding needs, through centralized bidding and block trading from March 11, 2026, to June 10, 2026. The reduction will not lead to a change in company control [1] Performance and Operating Conditions - The company forecasts a net loss attributable to shareholders of between 100 million to 150 million yuan for 2025, an improvement from a loss of 620 million yuan in 2024, primarily due to asset impairment in the real estate market and the impact of the Beijing Loyal Oncology Hospital project exit. Final figures will be confirmed in the official annual report expected to be released in 2026 [2] Company Status - A share transfer completed on January 22, 2026, resulted in Meihua Investment becoming the second-largest shareholder with a 10.38% stake, while Bubugao (002251) holds an indirect 19.08% stake. Market attention is on whether the new shareholders will drive business integration or resolve capital occupation issues, although no specific timeline has been publicly disclosed [3] Related Party Transactions - As of the end of 2024, the original controlling shareholder, Zhongzhu Group, and its affiliates have an outstanding capital occupation balance of 568 million yuan, which remains unpaid. The company has applied for compulsory enforcement through the courts. Future developments regarding repayment or judicial outcomes may impact corporate governance and risk warning status [4]

Group 1 - Fangda Carbon plans to acquire 100% equity of Tianjin Tongda Huanyu Logistics Co., Ltd. for 319 million yuan [1] - Xiamen Tungsten intends to acquire 39% equity of Jiujiang Dadi Mining Development Co., Ltd. and has signed an intention agreement with a transferor [6] - Wenkai Co. has won a bid for a landscape project worth 50.8162 million yuan [7] Group 2 - Changchun High-tech's subsidiary Jin Sai Pharmaceutical received approval for a clinical trial application for GenSci136, a treatment for IgA nephropathy [3] - China National Pharmaceutical has received drug registration certificates for fumaric acid volnoral tablets, used for treating reflux esophagitis [12] - Zhenhua Group plans to issue convertible bonds not exceeding 1.2 billion yuan [26] Group 3 - CSG Holding's stock may undergo a control change due to share pledge judicial transfer [30] - Ningbo Yunsheng plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [19] - Keda Guochuang's controlling shareholder intends to transfer 5% of the company's shares through an agreement [28] Group 4 - A number of companies, including Finer Pharma, Yixing Guoyuan Investment, and others, have announced plans to reduce their shareholdings by various percentages [2][4][9][11][15][16][20][21][22][23][25][29] - Highweida plans to repurchase shares worth 30 to 35 million yuan [17] - ST Zhongzhu is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [24] Group 5 - A number of companies, including Jiekang Equipment and others, have faced legal issues or penalties [27][40] - Aclaris Therapeutics has clarified that reports regarding its robotic products entering mass production were misinterpreted [41]

Group 1 - The controlling shareholder of Bowei Alloy plans to increase its stake in the company by 100 million to 150 million yuan [1] - The actual controller and directors of Congsheng Co. intend to reduce their holdings by no more than 5% of the company's shares [1] - Yinbei Investment of Senba Sensor plans to reduce its stake by no more than 3% of the company's shares [1] Group 2 - The controlling shareholder and its concerted parties of Liansheng Chemical plan to reduce their holdings by no more than 3% of the company's shares [1] - A shareholder of ST Zhongzhu intends to reduce its stake by no more than 3% of the company's shares [1] - Shareholders of Youde Precision (rights protection) plan to collectively reduce their holdings by no more than 3% of the company's shares [1] Group 3 - Shareholder Finer of Xuantai Pharmaceutical plans to reduce its stake by no more than 2% of the company's shares [1] - A shareholder of Far East Co. intends to reduce its holdings by no more than 1.5% of the company's shares [1] - A shareholder of Zhongzhou Special Materials plans to reduce its stake by no more than 1.4% of the company's shares [1] Group 4 - Qianhai Jin控 plans to reduce its stake in GCL-Poly Energy by no more than 1.01% of the company's shares [1] - The controlling shareholder of Keda Technology intends to reduce its holdings by no more than 1% of the company's shares [1] - Yulong Venture Capital plans to reduce its stake in Haiguo Co. by no more than 0.9965% of the company's shares [1] Group 5 - Shareholders of Lian Technology plan to collectively reduce their holdings by no more than 0.96% of the company's shares [1] - The controlling shareholder of Teda Co. intends to reduce its holdings by no more than 29.38 million shares [1] - The actual controller of Perfect World reduced its stake by 1.247 million shares during a period of abnormal stock fluctuations [1] Group 6 - A shareholder of Tengya Precision plans to reduce its stake by no more than 3.8 million shares [1]

Group 1 - Jinwei Co., Ltd. plans to acquire 100% equity of Fusheng Mining for 210 million yuan, which will become a wholly-owned subsidiary and included in the consolidated financial statements [2] - Mengguli intends to invest 929 million yuan to build a project with an annual production capacity of 30,000 tons of lithium-ion battery cathode materials, expected to produce 5,000 tons of high-voltage cobalt acid lithium, 10,000 tons of NCA materials, and 15,000 tons of ultra-high nickel ternary materials [2] - Xiamen Tungsten plans to acquire 39% equity of Jiujiang Dadi Mining, which will help increase mineral resource reserves and improve raw material self-sufficiency [3] Group 2 - Andavil's subsidiary received EASA certification for its aviation kitchen plug-in products, marking compliance with European aviation safety standards [2] - CIMC Vehicles disclosed that the US ITC made a preliminary ruling on anti-subsidy and anti-dumping investigations regarding Van-Type Trailers, indicating potential damage to the US domestic industry [4] - Source Technology plans to invest approximately 1.251 billion yuan to build a second phase project for the R&D and production of optoelectronic communication semiconductor chips and devices [9] Group 3 - Zhongmin Energy intends to acquire 51% equity of Mintou Pumped Storage for 864 million yuan, with the transaction price based on asset evaluation [10] - Ningbo Yunsheng plans to publicly issue H-shares and apply for listing on the Hong Kong Stock Exchange [11] - Wenkai Co., Ltd. won a bid for a landscape project worth 50.8162 million yuan [12] Group 4 - China Merchants Shekou achieved a signed sales amount of 7.674 billion yuan in January 2026 [16] - AVIC Optoelectronics reported a net profit of 2.124 billion yuan for 2025, a year-on-year decrease of 36.69% [17] - Tiankang Bio reported a sales revenue of 392 million yuan from pig sales in January 2026, with a month-on-month increase of 6.23% [18] Group 5 - Poly Developments reported a signed amount of 15.617 billion yuan in January 2026, a year-on-year decrease of 13.31% [19] - Chengtou Holdings reported a net profit of 290 million yuan for 2025, a year-on-year increase of 19.67% [20] - Qianjin Pharmaceutical reported a net profit of 288 million yuan for 2025, a year-on-year increase of 24.74% [21]

Core Viewpoint - ST Zhongzhu (600568.SH) announced the resignation of director Liu Huaping due to personal reasons, while he will continue to serve as the company's vice president and general manager of Zhuhai Zhongzhu Hongqi Investment Co., Ltd [1] Group 1 - The board of directors received Liu Huaping's written resignation report on February 9, 2026 [1] - Liu Huaping will retain his position as vice president and general manager after resigning from the board and related committees [1]

Group 1 - The company ST Zhongzhu (600568.SH) announced that its board received a written resignation report from director Liu Huaping on February 9, 2026 [1] - Liu Huaping resigned from his position as a director and committee member due to personal reasons [1] - After his resignation, Liu Huaping will continue to serve as the company's vice president and general manager of Zhuhai Zhongzhu Hongqi Investment Co., Ltd [1]

Core Viewpoint - ST Zhongzhu (600568.SH) announced that it received a notice from Zhongshengyuan regarding a share reduction plan due to its own funding needs, intending to reduce its holdings in the company through centralized bidding and block trading [1] Summary by Category Share Reduction Plan - Zhongshengyuan plans to reduce its holdings by no more than 59.7861 million shares, accounting for no more than 3% of the company's total share capital [1] - The reduction will occur through two methods: centralized bidding and block trading [1] Centralized Bidding Details - Under the centralized bidding method, the total number of shares reduced within any continuous 90 natural days will not exceed 1% of the company's total share capital, which is equivalent to no more than 19.9287 million shares [1] Block Trading Details - For the block trading method, the total number of shares reduced within any continuous 90 natural days will not exceed 2% of the company's total share capital, amounting to no more than 39.8574 million shares [1] - The implementation of the reduction will be based on the market price at the time of execution [1]